Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Irène Frachon

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Presse Medicale (Paris, France : 1983)|March 16, 2013
[About the settlement of litigations concerning the harm caused by benfluorex (Mediator®)]Philippe Nicot, Irène Frachon, Catherine Hill
Plos One|April 21, 2010
Benfluorex and unexplained valvular heart disease: a case-control studyIrène Frachon, Yves Etienne, Yannick Jobic, et al.
Presse Medicale (Paris, France : 1983)|August 25, 2010
[Contraception, therapeutic abortion, and pulmonary arterial hypertension]Irène Frachon, Stéphanie Pozzi Gaudin, Catherine Jezequel, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 26, 2016
Highlighting the impact of cascade carrier testing in cystic fibrosis familiesIngrid Duguépéroux, Carine L'Hostis, Marie-Pierre Audrézet, et al.
Molecular Biotechnology|March 9, 2004
CFTR transgene expression in primary DeltaF508 epithelial cell cultures from human nasal polyps following gene transfer with cationic phosphonolipidsTristan Montier, Pascal Delépine, Rémi Marianowski, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 7, 2014
T-cell therapy using a bank of EBV-specific cytotoxic T cells: lessons from a phase I/II feasibility and safety studyGéraldine Gallot, Solène Vollant, Soraya Saïagh, et al.
The European Respiratory Journal|April 24, 2012
Pulmonary hypertension associated with benfluorex exposureLaurent Savale, Marie-Camille Chaumais, Vincent Cottin, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Presse Medicale (Paris, France : 1983)|March 16, 2013
[About the settlement of litigations concerning the harm caused by benfluorex (Mediator®)]Philippe Nicot, Irène Frachon, Catherine Hill
Plos One|April 21, 2010
Benfluorex and unexplained valvular heart disease: a case-control studyIrène Frachon, Yves Etienne, Yannick Jobic, et al.
Presse Medicale (Paris, France : 1983)|August 25, 2010
[Contraception, therapeutic abortion, and pulmonary arterial hypertension]Irène Frachon, Stéphanie Pozzi Gaudin, Catherine Jezequel, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 26, 2016
Highlighting the impact of cascade carrier testing in cystic fibrosis familiesIngrid Duguépéroux, Carine L'Hostis, Marie-Pierre Audrézet, et al.
Molecular Biotechnology|March 9, 2004
CFTR transgene expression in primary DeltaF508 epithelial cell cultures from human nasal polyps following gene transfer with cationic phosphonolipidsTristan Montier, Pascal Delépine, Rémi Marianowski, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 7, 2014
T-cell therapy using a bank of EBV-specific cytotoxic T cells: lessons from a phase I/II feasibility and safety studyGéraldine Gallot, Solène Vollant, Soraya Saïagh, et al.
The European Respiratory Journal|April 24, 2012
Pulmonary hypertension associated with benfluorex exposureLaurent Savale, Marie-Camille Chaumais, Vincent Cottin, et al.
Pageof 1